Non-Licensed Product Royalties Sample Clauses

Non-Licensed Product Royalties. [Confidential treatment requested]
Sample 1
AutoNDA by SimpleDocs
Non-Licensed Product Royalties. AZ shall pay to ABX royalties equal to [Confidential treatment requested] of Net Sales of all Non-Licensed Products with respect to Collaboration Antigens or Discontinued Antigens and all Non-Antibody Products with respect to Failed Antigens, in each case sold by AZ and its Affiliates that are Derived through the use of (a) the Collaboration Technology, or (b) Information Derived through the use of Collaboration Technology (including the structure or other attributes of an Antibody-Antigen complex), unless such Collaboration Technology or Information could have been created (as reasonably demonstrated by AZ) [Confidential treatment requested] or was created (as reasonably demonstrated by AZ) using technology [Confidential treatment requested] during the applicable Royalty Term for such Non-Licensed Product or Non-Antibody Product, as applicable. For the avoidance of doubt, this Section 9.3.4 shall not apply to any Licensed Products or any Non-Licensed Products (other than Non-Antibody Products) with respect to Failed Antigens.
Sample 1
Non-Licensed Product Royalties. (a) Novo Nordisk shall pay to PCYC a royalty rate of [**] percent ([**]%) (“Non-[**] Royalty Rate”) on annual Net Sales of each Non-[**] Licensed Product during the Non-[**] Royalty Term (defined below)
Sample 1

Related to Non-Licensed Product Royalties

  • Licensed Product “Licensed Product” shall mean any article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights. For clarity, a “Licensed Product” shall not include other product or material that (a) is used in combination with Licensed Product, and (b) does not constitute an article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Third Party Royalties Each party shall be responsible for all of its own costs of commercializing Products or licensing Intellectual Property Rights, including any payments to Third Parties for work done by such Third Parties or for licenses necessary for the manufacture, sale, or use of Products by a party or its Affiliates or sublicensees.

  • Net Sales The term “

  • Marking of Licensed Products To the extent commercially feasible and consistent with prevailing business practices, Company shall xxxx, and shall cause its Affiliates and Sublicensees to xxxx, all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights that applies to such Licensed Product.

  • Licensed Territory Worldwide NIH Patent License Agreement—Exclusive APPENDIX C – ROYALTIES Royalties:

  • Sublicense Revenue In the event Licensee or an Affiliate of Licensee sublicenses under Section 2.2, Licensee shall pay CareFusion **THE CONFIDENTIAL PORTION HAS BEEN SO OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND HAS BEEN FILED SEPARATELY WITH THE COMMISSION.** of any Sublicense Revenues resulting from sublicense agreements executed by Licensee.

  • Sublicense Fees Licensee will pay Sublicense Fees indicated in Section 3.1(e) of the Patent & Technology License Agreement on or before the Quarterly Payment Deadline for the Contract Quarter.

  • Royalty Term Licensee shall have no obligation to pay any royalty with respect to Net Sales of any Licensed Product in any country after the Royalty Term for such Licensed Product in such country has expired.

  • Sublicensee The term “Sublicensee” shall mean any third party to whom Licensee grants a sublicense or similar rights with respect to the rights conferred upon Licensee under this Agreement, as contemplated by Section 2.3. In addition, “Sublicensee” shall include any and all further third party Sublicensees that may be permitted under Section 2.3.

Time is Money Join Law Insider Premium to draft better contracts faster.